LUTS & GREENLEIGH GROUP, INC BMY Holdings History
LUTS & GREENLEIGH GROUP, INC's Bristol-Myers Squibb Co Holding Summary
As of 2025-06-30, LUTS & GREENLEIGH GROUP, INC held - shares of Bristol-Myers Squibb Co(BMY), totaling N/A. This investment constitutes 0% of their stock portfolio, and LUTS & GREENLEIGH GROUP, INC now holds 0% of the outstanding Bristol-Myers Squibb Co(BMY) stock.
The initial trade took place in 2024Q2. And since then LUTS & GREENLEIGH GROUP, INC has made 2 purchases of BMY, at an average price of $44.92, for a total of 7,435.00 shares. In addition, there have been 3 sales at an average price of $48.25 for 7,435.00 shares. Based on historical transaction data and BMY's current price of $47.36, LUTS & GREENLEIGH GROUP, INC's estimated gain on his BMY holdings is $24,768.56, reflecting a 7.42% gain to date.
LUTS & GREENLEIGH GROUP, INC BMY ($47.36) Holding Chart
LUTS & GREENLEIGH GROUP, INC BMY ($47.36) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
